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Background. In this short communication, our focus is on the relationship between human 27 
concentrations of select persistent organic pollutants (POPs) and environmental emissions. It 28 
is based on a longitudinal study (1979-2007) conducted in Norway.  29 
Objectives. Our aim was to extract general insights from observed and predicted temporal 30 
trends in human concentrations of 49 POPs to assist in the design and interpretation of future 31 
monitoring studies.  32 
Discussion. Despite considerable decline for polychlorinated biphenyls (PCBs) and 33 
organochlorine pesticides (OCPs) since 1986, the sum of the targeted POPs increased from 34 
1979 until 2001, with per- and polyfluorinated alkyl substances (PFASs) dominating recent 35 
blood burden measurements. Specifically, the time trends in serum concentrations of POPs, 36 
exemplified by PCB-153, 1,1'-(2,2,2-Trichloroethane-1,1-diyl)bis(4-chlorobenzene) (DDT) 37 
and perfluorooctane sulfonic acid (PFOS), resembled the trends in available data on their 38 
emissions, production or use. These observations suggest that interpretations of human 39 
biomonitoring data on persistent compounds must consider historic emissions, which likely 40 
vary spatially across the globe. Based on the different temporal trends observed across POP 41 
groups, it is evident that generalizations regarding temporal aspects have limitations.  42 
Conclusion. The discussion herein underscores the importance of understanding temporal 43 
variations in environmental emissions when designing and interpreting human biomonitoring 44 




Humans worldwide are exposed to an array of anthropogenic substances in their everyday 47 
lives. The overall increase in the manufacture of man-made chemicals and industrial by-48 
products in the 20th century is deemed responsible (Egeghy et al., 2012). In addition to 49 
persistence POPs bioaccumulate, have the potential for long-range transport, and are toxic. 50 
Several international legislative agreements place restrictions or bans on the manufacture and 51 
use of several POPs. These and other initiatives aim to protect the environment and human 52 
health. Regulatory actions have indeed decreased the global manufacture and emissions of 53 
POPs (Breivik et al., 2007; Paul et al., 2009; Schenker et al., 2008). Each legacy POP or POP 54 
group has a unique emission history that is dictated by its past production and control 55 
strategies. For example, the estimated global emissions of PCB-153 in 2016 were ~3% of that 56 
in 1970 (Breivik et al., 2016). Since the terminology for estimated ‘emissions’ in the available 57 
literature varies, we define it as including the sum of environmental releases across the 58 
chemical life-cycle (manufacturing, use and disposal stages). 59 
Various human biomonitoring studies have demonstrated that blood concentrations of PCBs, 60 
OCPs and certain PFASs have decreased in many countries in recent years (Haug et al., 2009; 61 
Kato et al., 2011; Schröter-Kermani et al., 2012; Thomsen et al., 2007; Toms et al., 2014; Vo 62 
et al., 2008). Clearly, the knowledge of human concentrations and their predictor variables 63 
remains fragmented because studies vary in design, targeted study period, geographical 64 
location , as well as gender and age of the study subjects (Porta et al., 2008). For example, 65 
biomonitoring initiatives have been strongly biased towards industrialised countries as 66 
opposed to developing countries. Furthermore, the majority of human biomonitoring studies 67 
are of cross-sectional design and do not consider time-dependent changes in emissions when 68 
interpreting contaminant concentrations. More complete assessments of contaminant burdens 69 
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are lacking because most studies represent snapshots that include only a limited fraction of all 70 
detectable contaminants.  71 
In this commentary, we recapitulate intra-individual changes in concentrations of 24 PCBs, 16 72 
OCPs and 9 PFASs measured in a longitudinal study (1979-2007) involving a male 73 
Norwegian cohort (Nøst et al., 2013; 2014). Furthermore, we aim to extract features relevant 74 
for the design and interpretation of future biomonitoring studies, specifically: (i) temporal 75 
trends in relation to current emissions and potential geographical trends; and (ii), the relative 76 
and aggregate POP compositions across time. 77 
 78 
Materials and Methods 79 
The Tromsø Study is a population-based study in Tromsø (~70,000 inhabitants), which is the 80 
largest municipality in Northern Norway. Surveys in 1979, 1986-1987 (hereafter referred to 81 
as 1986), 1994-1995 (1994), 2001, and 2007-2008 (2007) allowed for a longitudinal design of 82 
repeated measurements. Based on gender, age group and geographic region (Alexander et al., 83 
2006; Bergsten 2004), the study subjects are assumed to have relatively frequent intakes of 84 
fish and dietary patterns, characteristic of Northern Norway and be representative for this age 85 
group in the region. The concentrations in these men are likely higher compared to the general 86 
Norwegian population due to their relatively advanced age and frequent consumption of fish. 87 
From 53 men for whom blood samples were available for at least three surveys in the Tromsø 88 
study, 254 serum samples were collected. The median ages at the five sampling points were 89 
43, 50, 58, 65, and 71. Details of the analytical methodology and quality assurance for the 90 
target compounds are provided in Nøst et al. (2013; 2014); all samples were analyzed in 2012 91 
at the laboratories of Norwegian Institute for Air Research. The results were compiled for 24 92 
PCBs (congeners 18, 28, 33, 47/49, 52, 99, 101, 105, 118, 123, 128, 138, 141, 149, 153, 156, 93 
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157, 167, 170, 180, 183, 187, 189, 194), 16 OCPs (α-, β-, µ-HCH, HCB, trans-, cis-, oxy-94 
chlordane, trans-, cis-nonachlor, Mirex, Toxaphene Parlar 26 and 50, p,p′-DDD, o,p′-, p,p′-95 
DDT, p,p′-, o,p′-DDE) and 9 PFASs (FOSA, PFDA, PFHpA, PFHpS, PFHxA, PFHxS, 96 
PFNA, PFOA, PFOS; for abbreviations see Nøst et al. 2014). Mixed models were used to 97 
assess the time trends of POPs in serum, and details of the data treatment and statistical 98 
approaches employed were as described in the references mentioned.  99 
 100 
Results 101 
The observed longitudinal trends from 1979 to 2007 of PCBs, OCPs, and PFASs in sera of 102 
Northern Norwegian males are summarized in Figure 1 and Table 1 (Nøst et al., 2013; 2014). 103 
The temporal trends differed among compounds during the 28-year period, and the aggregated 104 
POP concentrations increased until 2001. In general, the concentrations of PCBs decreased 105 
from 1979 or 1986 on, whereas the OCPs did so from 1979. Summed PFASs increased five-106 
fold from 1979 to 2001 and then decreased; the longer chained perfluoroalkyl carboxylic 107 
acids also increased throughout this period.  108 
PFASs, DDTs and PCBs contributed almost equal proportions to the summed concentrations 109 
in 1979, while PFASs have dominated subsequently (Table 1 and Figure 1).  110 
The Spearman`s ρ correlations for PCB-153 with other POPs spanning the sampling years 111 
were robust (ρ ≥ 0.95) for many compounds, such as the higher chlorinated PCBs, and 112 
moderate (ρ > 0.6) for others (e.g., trans-Nonachlor, p,p'-DDE, toxaphene Parlar 26 and 113 
HCB). Correlations were weaker for HCHs (ρ<0.6) and most PFASs (e.g. ρ<0.3 for PFOA 114 
and ρ<0.4 for PFOS).   115 
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Discussion  116 
Interpretation of temporal trends of POPs in Northern Norway in relation to emissions 117 
inventories 118 
Figure 1 reveals that the summed concentrations of the measured POPs increased considerably 119 
from 1979 to 2001 and was driven primarily by the increase in PFASs, decreasing thereafter 120 
(2001-2007). Compound-specific changes in human concentrations during this observation 121 
period appear convincingly coherent with those depicted for past emissions for individual or 122 
groups of contaminants. This is illustrated in Figure 2 for the divergent time trends shown for 123 
PCBs, OCPs and PFASs. As there has been no production of any of these compounds in 124 
Norway, exposure is likely linked to a combination of historic imports and uses, long-range 125 
transport (Armitage et al., 2009; Mantseva et al., 2004), and their presence in food items (Haug 126 
et al., 2010). Our biomonitoring and modelling results highlight that human temporal trends are 127 
also influenced by compound-specific delays between chemical imports, environmental 128 
emissions, and degradation/elimination rates (Alcock et al., 2000; Quinn and Wania 2012; 129 
Ritter et al., 2009). Using PCB-153 as an example (see Figure 3), we conclude that these delays 130 
may be significant and reflect: (i) time-lags between production/import and emissions due to 131 
the long lifetime of PCB-containing products; and (ii), delays between peaks in emissions, 132 
environmental/food-chain exposures and human concentrations. Further, the timing of peaks in 133 
environmental exposures for each compound is modulated by media-specific degradation rates 134 
as well as the modes of environmental transport. Estimations of these processes by mechanistic 135 
modeling are presented for PCB-153 in Figure 3 and are discussed by Breivik et al. (2010) and 136 
Quinn and Wania (2012).  137 
Clearly, accurate knowledge of emissions for various compounds over time is critical for the 138 
interpretation of time trends. Dynamic multimedia mechanistic models may provide 139 
7 
 
quantitative links between emissions and human exposures (MacLeod et al., 2010). For certain 140 
PCBs, estimates of the median concentrations in the present study group were obtained from 141 
one such model, the CoZMoMAN model, which convincingly reconstructed the measured 142 
concentrations and their time trends (Nøst et al., 2013). This strengthened our hypothesis that 143 
empirical time trends are largely dictated by changes in emissions. While significant efforts 144 
have been invested in the development of emission inventories for some POPs that are emitted 145 
as by-products of combustion (e.g., Pacyna and Graedel, 1995), obtaining accurate information 146 
on rates of production, use and/or emissions of intentionally produced organic contaminants 147 
has proven challenging. Confidentiality issues appear to be partly responsible (Breivik et al., 148 
2012). Further, fate properties are divergent for different POPs in various environmental media 149 
and humans, including degradation and metabolism/elimination half-lives, respectively (Figure 150 
3). This also highlights a chemical-specific approach to POPs, even within groups of related 151 
compounds. From the clear links between trends in emissions and human concentrations of 152 
POPs observed in the Tromsø study, it seems pertinent to assess whether similar or divergent 153 
temporal trends in human body burdens might be anticipated globally. 154 
Reduced emissions of PCBs and OCPs has had an impact on human blood concentrations, but 155 
these compounds constitute only a small fraction of the total exposure to contaminants in the 156 
Norwegian cohort by 2007 (Nøst et al., 2013; 2014). Similar declines across recent decades 157 
are reported in many industrialized countries (e.g., Hagmar et al., 2006; Thomsen et al., 2007; 158 
Vo et al., 2008). Phasing out and placing restrictions on use of PFOS and PFOA have led to 159 
decreasing concentrations after 2001, but their contributions to total body burden nevertheless 160 
remain high in 2007. The declines of PFOS and PFOA in recent years are also described for 161 
other industrialized countries (Gebbink et al., 2015; Haug et al., 2009; Kato et al., 2011; 162 
Schröter-Kermani et al., 2012). As observed for PCBs, OCPs and PFASs, the lowering of 163 
emissions has clearly been effective in reducing human concentrations in Tromsø, and this 164 
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pattern is likely to occur in many other industrialized countries where these chemicals were 165 
extensively produced and/or used.  166 
One factor that may cause divergent trends globally is attributed to the long lifetime of 167 
various use categories of products containing organic contaminants; they represent potential 168 
emission sources long after initial regulatory actions (Diamond et al., 2015). An example is 169 
the elevated emissions from informal waste or recycling processes in developing regions, such 170 
as of PCBs and other organic contaminants (e.g., PBDEs) released from waste electrical and 171 
electronic equipment (Breivik et al., 2011; Robinson 2009; Zhang et al., 2012). Thus the 172 
effectiveness of reducing human exposure to POPs in many countries can be improved by 173 
adopting environmentally sound practices to remove and process products and materials 174 
containing these compounds. Furthermore, export of e-wastes to developing regions offer a 175 
disturbing example of how temporal emissions trends of POPs may be spatially and 176 
temporally separated from those in areas where these chemicals were produced and used 177 
(Breivik et al., 2011). Indeed, elevated concentrations in humans in areas influenced by such 178 
activities have been reported (Grant et al., 2013; Wang et al., 2014; Wittsiepe et al., 2015). In 179 
Ghana, known to import of electronic waste (Schluep et al., 2011), concentrations of PCBs 180 
and PBDEs in breast milk samples increased from 2004 to 2009 (Asante et al., 2011). 181 
Furthermore, recent plasma concentrations of PCBs in Ghanaian immigrants to the Canary 182 
Islands (Luzardo et al., 2014) were higher compared to those in the Norwegian cohort even in 183 
1979 (respectively, medians of 503 and 360 ng/g lipid weight for PCB-153). Although 184 
temporal trends of the legacy POPs clearly indicate reduced human exposure to these 185 
compounds in industrialized countries, the trends in developing countries do not necessarily 186 
conform. This illustrates that emission trends and human exposures may be spatially variable 187 
across the globe, due to transboundary exports of hazardous waste for example. Other factors 188 
may also create differences in temporal trends even in a post-ban situation, with population 189 
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dietary transitions an example (Quinn et al., 2012). Consequently, results from regional 190 
biomonitoring studies are not necessarily universally applicable. Temporal trends in emissions 191 
and influences of population-specific confounding factors must be considered. 192 
 193 
Dynamic POP compositions  194 
The 49 compounds included in this longitudinal study enabled a detailed assessment of how 195 
the sum of all compounds and their relative contributions have varied across the 30-year study 196 
period. Compound-specific and time-variant emissions of POPs have resulted in complex and 197 
dynamic burdens of POPs in human blood as depicted in Figure 1. Although age and birth 198 
year are confounded in cross-sectional studies, the time trends in this longitudinal study were 199 
confounded only by age. Clearly, the interpretation of differences in POP concentrations due 200 
to age (both within and between persons) in biomonitoring studies are conditional on the time 201 
of sampling and the age distribution of a study population in relation to historic emissions 202 
(Alcock et al., 2000; Quinn and Wania, 2012).  203 
The changes in relative proportions of POPs are also reflected in the inter-compound 204 
correlations. Overall, moderate or strong correlations over time suggest similar emission 205 
histories, exposure pathways and persistence in the environment and humans. PCB-153 has 206 
been suggested as a suitable marker for PCBs and other POPs (Covaci et al., 2002; Glynn et 207 
al., 2000). As reported above, inter-correlations between PCB-153 and other PCBs (e.g., 208 
PCB-180) were very robust in the Norwegian study, and this was also evident for OCPs like 209 
HCB. By contrast, the newer POPs like PFOA and PFOS did not associate with PCB-153 at 210 
any time point. Thus, the latter is less representative of the total exposure to halogenated 211 
compounds in the Norwegian cohort in 2007 compared to 1979, and thereby its potential as a 212 
single marker has been reduced in the years beyond the peak exposure to legacy POPs. 213 
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Subsequently, the potential use of PCB-153 as a marker for summed POP exposure that 214 
include emerging contaminants with dissimilar physicochemical properties and historic 215 
emissions has been diminished.  216 
The number of organic and inorganic chemicals introduced on the global market has increased 217 
substantially in the past few decades, and more than 100,000 substances are used 218 
commercially today (Egeghy et al., 2012). It is thus likely that the human body burden of 219 
contaminants include chemicals currently in use that have not received the attention of 220 
researchers, and thus could indeed be contaminants of concern (i.e., based on persistence, 221 
bioaccumulation potential, and toxicity; Arnot et al., 2012). .  222 
Based on the above considerations, it appears fair to hypothesize that the summed 223 
concentrations of POPs described in Figure 1 cover merely a fraction of the chemicals present 224 
in humans today. Indeed, a number of other contaminants have been detected in human blood 225 
in Norwegian studies, including pentachlorophenol and hydroxylated PCBs (Rylander et al., 226 
2012) and emerging brominated flame retardants (Thomsen et al., 2002). Furthermore, the 227 
screening of contaminants in the US NHANES monitoring studies has targeted 267 228 
chemicals, and many of them were detected in serum/blood (CDC 2015; Crinnion 2010). 229 
Non-POP compounds with short half-lives have recently been quantified in humans such as 230 
parabens in Norwegians (Sandanger et al., 2011), although continuous use appears to lead to 231 
elevated exposures. Overall, both summed concentrations as well as the complexity of the 232 
total human burden of contaminants can be expected to increase in the coming years. Thus 233 
ongoing monitoring of human contaminant concentrations should ideally include both legacy 234 
pollutants as well as chemicals still produced and used.  235 
  236 
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Concluding remarks  237 
As exemplified by PCB-153, DDT and PFOS, the time trends in human concentrations of 238 
POPs in this longitudinal sample dataset resemble those of their production, use and emission. 239 
Our findings highlight the importance of available and accurate data on trends of emissions of 240 
individual substances to interpret human biomonitoring studies. A complicating factor is that 241 
the trends described may vary spatially across the globe. To address this dimension, informal 242 
e-waste recycling and increasing concentrations reported in certain countries where this 243 
occurs serves as an example that could guide the selection of geographical areas relevant for 244 
conducting related human biomonitoring studies. Clearly, the blood compartment burden of 245 
POPs is dynamic, and thus is likely to increase in complexity related to ongoing exposures to 246 
compounds currently in use. Future biomonitoring efforts are encouraged to target a broad 247 
range of compounds with different physicochemical properties and populations experiencing 248 
unique and divergent emission histories. 249 
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Table 1: Percent contribution for the different POP groups to the summed measured burden in 397 
five sampling years for 53 Norwegian men in the Tromsø Study based on the data reported in 398 







a∑ signifies the summed concentrations in each group and the subscript the number of compounds in 406 
each group. 407 
  408 
Compoundsa 1979 1986 1994 2001 2007 
ΣHCHs3 2 1 0 0 0 
ΣDDTs5 26 12 5 3 3 
HCB 4 2 1 1 1 
Σchlordanes5 2 2 1 1 1 
Σtoxaphenes2 1 1 0 0 0 
ΣPCBs24 30 19 12 9 9 
PFOS 20 36 45 51 52 
Σother PFASs8 16 27 35 34 33 
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Figure legends 409 
 410 
Figure 1.  411 
Wet-weight concentrations of PCBs, OCPs, and PFASs from 1979 to 2007 for 53 men based on the 412 
data reported in Nøst et al. (2013; 2014; reproduced with permission from Environmental Health 413 
Perspectives and Environment International) for repeated measurements of men in the Tromsø Study. 414 
PFOS represents the sum of linear and branched forms. See Table 1 for the number of compounds in 415 
each sum.  416 
 417 
Figure 2. 418 
The horizontal axes represent calendar years, left vertical axes the emissions/production volumes in 419 
thousands tons (colored areas), and right vertical axes the wet-weight serum concentrations in the five 420 
repeated measurements from Norwegian men (bars; n=53). A: Estimated regional emissions for PCB-421 
153 from 1930 to 2020 (adapted from Breivik et al., 2007) are displayed along with the measured 422 
serum concentrations of PCB-153. B: Estimated global emissions of DDT from 1941 to 2005 adapted 423 
with permission from Schenker et al., (2008; Copyright American Chemical Society) conjointly with 424 
the serum concentrations of p,p′-DDT. C: Estimated global production volumes of the PFOS-related 425 
perfluorooctanesulfonyl fluorides from 1970 to 2005 (adapted with permission from Paul et al., 2009; 426 
Copyright American Chemical Society) are shown along with the serum concentrations of PFOS (sum 427 
of linear and branched). 428 
 429 
Figure 3. 430 
Estimated trends in emissions and concentrations from 1930 to 2050 for PCB 153 scaled to the 431 
maximum value for each medium. Note that the trends for air and dairy products overlap and are 432 
presented as one line. The plotted curve for the 29-year old woman refers to blood concentrations after 433 
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nursing her first child for 6 months. Further details of the model parameterization are presented in 434 
Breivik et al. (2010) and references therein, and as later explored by Nøst et al (2013). 435 



